CAL-101, a p110delta selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability - Lannutti, B J; Meadows, S A; Herman, S E (Blood, 2011)
et al.